Drug class
Fifth-generation cephalosporin prodrug; beta-lactam antibacterial
Mechanism of action
Ceftaroline fosamil is converted by phosphatases to active ceftaroline. Ceftaroline binds penicillin-binding proteins, including PBP2a in methicillin-resistant Staphylococcus aureus (MRSA), and inhibits bacterial cell-wall synthesis.
General use cases
- Treatment of acute bacterial skin and skin-structure infections, including those caused by susceptible MRSA
- Treatment of community-acquired bacterial pneumonia caused by susceptible pathogens; exact age and organism criteria are product-label specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
